Cost-effectiveness in stroke prevention - Adding value.

Topic: Primary cardiovascular prevention: interventions and outcomes
Sponsored by the Bristol-Myers Squibb and Pfizer alliance

About the speaker

Professor Paul Dorian

St. Michael's Hospital, Toronto (Canada)
0 follower

5 more presentations in this session

Stroke prevention in non-valvular atrial fibrillation: the reality.

Speaker: Professor C. Granger (Durham, US)

Thumbnail

Current treatment behaviours in Europe for stroke prevention in non-valvular atrial fibrillation.

Speaker: Professor P. Kirchhof (Hamburg, DE)

Thumbnail

Addressing the unmet clinical need: role of noval oral anticoagulants.

Speaker: Professor C. Granger (Durham, US)

Thumbnail

Preventing stroke in non-valvular atrial fibrillation: practical guidance.

Speaker: Professor H. Diener (Essen, DE) Professor S. Kristensen (Aarhus, DK)

Thumbnail

Concluding summary and Q&A: stroke prevention in non-valvular atrial fibrillation.

Speaker: Professor S. Middeldorp (Amsterdam, NL)

Thumbnail

Access the full session

Stroke prevention in non-valvular atrial fibrillation - Improving patient outcomes

Speakers: Professor P. Dorian, Professor C. Granger, Professor P. Kirchhof, Professor C. Granger, Professor H. Diener...
Thumbnail

About the event

Image

ESC Congress 2013

31 August - 4 September 2013

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb